Bio Decontamination Market Size & Share, by Product (Equipment, Service, Consumables); End-user (Biotech, Medical Devices, Pharma, Life Sciences, Hospital); Agent (Chlorine, Hydrogen Peroxide, Nitrogen, Peracetic Acid) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3893
  • Published Date: Mar 31, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2035

Bio Decontamination Market size is expected to reach USD 315 million by the end of 2035, growing at a CAGR of 6% during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of bio decontamination was over USD 140 million. Further, the market generated a revenue in the year 2022 owing to the increased number of surgical procedures giving rise to higher risk of post-operative infections. Based on Eurostat statistics, a total of 1.12 million C-section surgeries were performed in the EU-27 alone in 2020. In that same year, roughly 4.3 million cataract surgeries took place in the region. A total of 3,00,800 heart bypasses are performed each year worldwide. Each year, 220,000 surgical procedures are performed in the United States, compared with 45,000 in India. Additionally, the rise in the number of surgeries is also attributable to the availability of advanced medical technologies, which allows surgeons to execute more complicated procedures with greater accuracy, thus leading to faster recovery times and a lower risk of post-operative infection. This has led to an increased demand for biodecontamination services, as hospitals and medical centers strive to reduce the risk of post-operative infections.

There are a number of levels of decontamination that can be performed on a device, including physical cleaning, ultra-sonication, disinfection, antisepsis, sterilization, and others. Physical cleaning involves the removal of dirt and debris from surfaces, while ultra-sonication uses sound waves to break up cells and debris. Disinfection is used to kill microorganisms, while antisepsis is used to reduce the number of microorganisms present on surfaces. Sterilisation is the complete removal of all living organisms, and other methods such as fumigation and chemical treatments are used to reduce the number of microorganisms present in an environment.

Decontamination is important because it eliminates any potential pathogens that may be present and can help reduce the risk of infection to patients, visitors, and healthcare workers. Additionally, it helps to prevent the spread of infectious diseases, especially in healthcare settings where the number of people in close contact is high.  

Additionally, the growing popularity of reusable medical devices in healthcare and medical settings is expected to fuel market growth as reusable medical devices can benefit healthcare facilities and patients by reducing costs, increasing safety, and improving the quality of medical care. Furthermore, reusable medical devices are preferred over disposable medical devices owing to their easy handling and convenience. In addition, the increasing number of regulatory guidelines issued by health authorities for the effective decontamination of reusable medical devices is expected to drive the market growth. These guidelines emphasize the importance of decontamination of reusable medical devices to reduce the risk of contamination and infection. Moreover, the growing awareness of healthcare-associated infections and their prevention is also anticipated to propel the bio decontamination market growth.

Bio Decontamination Market
Get more information on this report: Request Free Sample PDF

Bio Decontamination Sector: Growth Drivers and Challenges

Growth Drivers

  • An Increase in The Rate of Hospital-Acquired Infections (HAIs) In Healthcare Settings - The increased prevalence of antibiotic-resistant bacteria, the growth of immunocompromised patient populations, and the lack of effective cleaning and disinfection practices are resulting in HAIs. These microorganisms can be spread through contact with contaminated surfaces and objects, as well as through contact with other people. They can also be spread through the air, which is why it is important to maintain good hygiene and ventilation in hospitals. Approximately 1.7 million hospitalized patients acquire HAIs each year, and 98,000 of these patients die from them. There are estimated to be 35,000 hospital acquired infections (HAI) caused by multidrug-resistant organisms (MDRO) each year in Germany, and approximately 1500 people die from them. According to a new report on healthcare-associated infections, Canada has approximately 220,000 hospital-acquired infections each year. As a result, the need for advanced infection control systems is on the rise, which is expected to drive market growth over the forecast period.
  • Rising Infections of SARS-Cov-2 Acquired in Hospitals- As the number of SARS-Cov-2 infections rises, hospitals are looking for ways to reduce the risk of infection among their staff and patients. According to the study, 12.3% of hospitalized patients in China who had initially been admitted for other reasons had suspected hospital-associated transmission. Biodecontamination is a process that uses chemicals, heat, or ultraviolet light to sterilize equipment and surfaces, making it an increasingly attractive option for hospitals to help prevent the spread of infection.
  • Emerging Biodecontamination Technologies And Services - For instance, the Rapid Bio Decontamination Service from Bioquell provides a full-service decontamination solution that eliminates microorganisms from the environment using Hydrogen Peroxide Vapor. The Hydrogen Peroxide Vapor works by permeating surfaces and killing any microorganisms present, while the vapor is also broken down into oxygen and water, which are harmless to humans and the environment.
  • The Lack Of Proper Hygiene In Hospitals Contributing To HAIs - According to the World Health Organization, half of all health care facilities do not provide basic hygiene services. A global survey found that one out of every ten health care facilities did not have access to sanitation. There were 3% of health care facilities without sanitation in Latin America and the Caribbean, 8% in eastern and south-eastern Asia, and 22% in sub-Saharan Africa. Only 1 in 5 health facilities in Least Developing Countries (21%) had basic sanitation.
  • An Increase in Healthcare Spending Worldwide - With more people accessing healthcare, the need for medical facilities to keep their environment sterile and prevent the spread of infection has become more critical. It was observed that healthcare spending in the United States reached USD 4.1 trillion in 2020, representing 19.7% of GDP, according to a report released by the Centers for Medicare & Medicaid Services. 


  • Lack of Awareness of the Benefits of Biodecontamination in Lower Socioeconomic Areas - People who live in lower socioeconomic areas tend to have less access to education and information about the benefits of biodecontamination. This means that they are not aware of the potential benefits of using biodecontamination techniques, which leads to them not using it and hindering market expansion.
  • High Cost of Bio Decontamination Services, The Lack of Trained Personnel
  • The Stringent Regulations and Standards Associated with The Operations.

Bio Decontamination Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2022)

~USD 140 Million

Forecast Year Market Size (2035)

~USD 315 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Bio Decontamination Segmentation

Product (Equipment, Service, Consumables)

The global bio decontamination market is segmented and analyzed for demand and supply by product into equipment, service and consumables. Out of these segments, the equipment segment is estimated to gain the largest market share by the end of year 2035. The growth of the segment can be attributed to the growing demand for disinfection services in the healthcare and pharmaceutical industries. These industries are increasingly investing in bio decontamination equipment as a way to reduce costs, improve safety, and ensure product quality. Additionally, the growing prevalence of infectious diseases, such as COVID-19, has increased the demand for decontamination equipment. Moreover, the segment growth is further driven by the increasing importance of decontamination technologies in various industries, such as the healthcare and food industries, that require advanced automated decontamination systems to ensure safety and quality. For instance, a new biodecontamination technology offered by Bioquell, which uses a 35% hydrogen peroxide vapour to reduce the level of contamination in cleanroom equipment, isolators, BSCs, rooms, pass-throughs, as well as emergency response and scheduled maintenance options. Additionally, the growing demand for automated decontamination equipment, driven by the need to reduce labor costs and improve efficiency, is expected to further boost the segment growth of the market.

End-user (Biotech, Medical Devices, Pharma, Life Sciences, Hospital)

The global bio decontamination market is also segmented and analyzed for demand and supply by end user into biotech, medical devices, pharma, life sciences and hospitals. Out of these segments, the medical devices segment is estimated to gain the largest market share by the end of year 2035. The growth of the segment can be attributed to the rising demand from the healthcare industry for decontamination of medical equipment in order to reduce the risk of infections. This is in conjunction with an increase in chronic disease cases and an increase in minimally invasive surgical procedures. The Centers for Disease Control and Prevention report that 51.8% of US adults have at least one chronic condition, and 27.2% have multiple chronic conditions. Additionally, the rise in the number of hospitals and healthcare centers, and the growing investments in healthcare infrastructure are contributing to the growth of the segment. Growing awareness among consumers regarding hygiene and safety, as well as the increasing demand for antimicrobial products to reduce contamination in medical devices is expected to drive the segment growth in the coming years.

Our in-depth analysis of the global market includes the following segments:

       By Product


  • Equipment
  • Service
  • Consumables

      By End User


  • Biotech
  • Medical Devices
  • Pharma
  • Life Sciences
  • Hospital

     By Agent

  • Chlorine
  • Hydrogen Peroxide
  • Nitrogen
  • Peracetic Acid

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Bio Decontamination Industry - Regional Synopsis

North American Market Forecast

The North American bio decontamination market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market can be attributed the growing awareness among the public about the potential hazards posed by microbial contamination, which caused an increase in the demand for bio decontamination solutions in the region. Additionally, the increasing adoption of advanced decontamination technologies, such as UV-C, ozone, and hydrogen peroxide, has further propelled the market growth in the region. Moreover, the large number of pharmaceutical companies in region such as Johnson & Johnson, Eli Lilly and Co, Pfizer Inc, and Merck & Co Inc., which require the use of bio decontamination techniques to safely produce drugs and treatments is expected to fuel regional market growth. Furthermore, recent advancements in biotechnology have enabled the development of more advanced and advanced bio decontamination technologies, which are also driving investments and spending in the field. For instance, almost half of global pharmaceutical production (47%) and 23% of the industry are produced in the US. Based on the Congressional Budget Office's estimate, the pharmaceutical industry spent USD 83 billion on research and development in 2019.

APAC Market Statistics

The Asia Pacific bio decontamination market, amongst the market in all the other regions, is projected to hold the second largest share during the forecast period. The growth of the market can be attributed to the rising number of healthcare-associated infections, increasing prevalence of chronic and communicable diseases, the growing demand for cleanroom sterilization, and the growing demand for bio decontamination services. Moreover, the growing geriatric population in the Asia Pacific region has contributed to an increase in the number of elderly people requiring specialized medical care. It is estimated that the Chinese population is aging at one of the fastest rates in the world. China's population over 60 is expected to grow to 28% by 2040. Over the next ten years, the number of older Indians (60 and over) is expected to more than double from 139 million to 195 million, an increase of 40%. Infectious diseases are more likely to infect elderly people since they visit hospitals frequently and have weakened immune systems. As a result, there is increased demand for biodecontamination solutions to mitigate the risk of healthcare-associated infections.

Europe Market Forecast

Further, the bio decontamination market in the Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The growth of the market can be attributed to the growing demand for bio-decontamination in the pharmaceutical industry owing to its safety and efficacy, as well as the increasing prevalence of nosocomial infections. The use of antibiotics has caused bacteria to become resistant, leading to an increase in the number of nosocomial infections. To combat this, bio decontamination is necessary to reduce the risk of spreading disease and infection. Additionally, growing awareness regarding the need for bio-decontamination along with the increased use of antibiotics, which has created an urgent need for bio-decontamination solutions is expected to fuel the growth of the market in the region. As a result, governments in the region have become more stringent with their regulations regarding bio-decontamination protocols in pharmaceutical facilities, resulting in an increase in the use of these products and services.

Research Nester
Bio Decontamination Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Bio Decontamination Landscape

    • Ecolab Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • TOMI Environmental Solutions Inc.
    • Howorth Air Technology Ltd.
    • Wenzhou Weike Biological Laboratory Equipment Co. Ltd.
    • JCE Biotechnology
    • Zhejiang Tailin Bioengineering Co., Ltd.
    • ClorDiSys Solutions Inc.
    • Amira S.r.l.
    • Noxilizer Inc.

In the News

  • A partnership between Steris and Chargepoint provides integrated solutions for sterile transfer, combining Steris' Biodecontamination Systems and Chargepoint's AseptiSafe Bio Transfer Valve.

  • Bioquell, a bio decontamination system offered by Ecolab Inc., was featured at the Tampa Convention Center in Florida. The Bioquell system is designed to provide a complete decontamination solution for healthcare and life science facilities, and its use at the convention center was intended to help keep the facility safe and clean

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 3893
  • Published Date: Mar 31, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rise in number of hospitals acquired infections along with increasing number of surgeries being performed in hospitals are the major factors expected to drive the market growth.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2035.

Lack of awareness of bio decontamination services in low income areas and the stringent regulations and standards associated with the operations.

The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Ecolab Inc., STERIS PLC, TOMI Environmental Solutions Inc., Howorth Air Technology Ltd., Wenzhou Weike Biological Laboratory Equipment Co. Ltd., JCE Biotechnology, Zhejiang Tailin Bioengineering Co., Ltd., ClorDiSys Solutions Inc., Amira S.r.l., Noxilizer Inc., and other key market players.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, end user, agent and by region.

The equipment segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Bio Decontamination Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying